The researchers evaluated socioeconomic data from the 2011 Combining Medications to Enhance Depression Outcomes (CO-MED) study to ascertain whether social determinants affect treatment response in those with major depression.
Virtual reality has been explored as an adjunct to cognitive behavioral therapy, but little is known about how well it delivers automated therapy. To find out, the researchers conducted a clinical trial using 9 National Health Service trusts in England.
Researchers examined the effect of neuropeptides orexin-A, ghrelin, and neuropeptide Y on hypersomnia and hyperphagia. Both symptoms are more common in people with bipolar disorder.
The results of a genome-wide association study may help researchers develop more tailored treatments to help patients who don’t respond to conventional antipsychotic medications.
With people who have major psychiatric disorders being more likely to have comorbidities which could lead to worse results concerning COVID-19, researchers using a US database assessed the odds of testing positive for COVID-19, as well as mortality from COVID-19.
Depressive symptoms and sleep disorders, including insomnia, hypersomnia, and disrupted breathing, are considered heart disease risk factors. Other studies have linked sleep disorders and depression. This study analyzes heart disease risk in people with both sleep disorders and depression.
Based on the theory that relaxing the facial muscles used to express negative emotions reduces the intensity of those emotions, the researchers explored the connection between BoNT injections and anxiety.
Authors analyzed the documentation of primary care professionals from electronic health records (EHRs) to find out the rate of PTBM recommendation for 4-5 year old patients with an ADHD diagnosis, ADHD symptoms or who were prescribed ADHD medication.
This study examines patient preferences for physicians with cultural competency among patients with depression and anxiety.
Researchers examined the extent cannabis use is associated with magnetic resonance imaging–measured cerebral cortical thickness development during adolescence.
